by In2Pharma | May 24, 2018 | News
Belgium The CMDh has updated the Blue Box requirements on 2 March 2018. Henceforth, mentioning the reimbursement category on the labeling of medicinal products is no longer required in Belgium. Marketing authorization holders are required to remove the reimbursement...
